Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative evaluation of authorized drugs for treating Covid‐19 patients
Towhidul Islam, Moynul Hasan, Mohammad Saydur Rahman, et al.
Health Science Reports (2022) Vol. 5, Iss. 4
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

The WHO has declared the end of pandemic phase of COVID‐19: Way to come back in the normal life
Rapty Sarker, A. S. M. Roknuzzaman, Nazmunnahar Nazmunnahar, et al.
Health Science Reports (2023) Vol. 6, Iss. 9
Open Access | Times Cited: 46
Repositioning potentials of smallpox vaccines and antiviral agents in monkeypox outbreak: A rapid review on comparative benefits and risks
Md. Rabiul Islam, Md. Jamal Hossain, Arpita Roy, et al.
Health Science Reports (2022) Vol. 5, Iss. 5
Open Access | Times Cited: 57
Insights into the Adsorption Properties of Mixed Matrix Membranes (Pebax 1657-g-Chitosan-PVDF-Bovine Serum Albumin@ZIF-CO3-1) for the Antiviral COVID-19 Treatment Drugs Remdesivir and Nirmatrelvir: An In Silico Study
Iman Salahshoori, Narjes Montazeri, Amirhosein Yazdanbakhsh, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 26, pp. 31185-31205
Closed Access | Times Cited: 33
The latest Omicron BA.4 and BA.5 lineages are frowning toward COVID‐19 preventive measures: A threat to global public health
Md. Rabiul Islam, Mohammad Shahriar, Mohiuddin Ahmed Bhuiyan
Health Science Reports (2022) Vol. 5, Iss. 6
Open Access | Times Cited: 34
Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens
Irfan Ullah, Fanny Escudié, Ivan Scandale, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109049-109049
Open Access | Times Cited: 6
Key allosteric and active site residues of SARS-CoV-2 3CLpro are promising drug targets
Kenana Al Adem, Juliana C. Ferreira, Samar Fadl, et al.
Biochemical Journal (2023) Vol. 480, Iss. 11, pp. 791-813
Open Access | Times Cited: 14
Prevalence and associated factors for elevated fear and depressive symptoms among the private service holders in Bangladesh during the Covid‐19 pandemic: A cross‐sectional study
Md. Rabiul Islam, Zabun Nahar, Md. Sakhawat Hossain, et al.
Health Science Reports (2022) Vol. 5, Iss. 5
Open Access | Times Cited: 20
COVID-19 Pharmacotherapy in Pregnancy: A Literature Review of Current Therapeutic Choices
Karolina Akinosoglou, Georgios Schinas, Emmanouil-Angelos Rigopoulos, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 787-787
Open Access | Times Cited: 10
Characteristics of the SARS-CoV-2 Omicron (B.1.1.529) Variant and Emerging Impact on Global Public Health
Md. Rabiul Islam, Waheeda Nasreen, Ramisa Anjum, et al.
Clinical Pathology (2022) Vol. 15
Open Access | Times Cited: 17
Effectiveness of estrogen and its derivatives over dexamethasone in the treatment of COVID-19
Darakhshan Parveen, Anwesha Das, Shaista Amin, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 4, pp. 1858-1874
Closed Access | Times Cited: 8
Water-soluble compounds from Lignosus rhinocerus TM02® (xLr™) modulate ACE2 activity and inhibit its interaction with SARS-CoV-2 spike-protein
Neng-Yao Goh, Yeannie H. Y. Yap, Chyan Leong Ng, et al.
Food Bioscience (2024) Vol. 59, pp. 104232-104232
Closed Access | Times Cited: 2
Potential of traditional medicines in alleviating COVID-19 symptoms
Moragot Chatatikun, Hiroko P. Indo, Motoki Imai, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Severe COVID-19versusmultisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection
Rupsha Fraser, Aurelio Orta‐Resendiz, David H. Dockrell, et al.
European Respiratory Review (2023) Vol. 32, Iss. 167, pp. 220197-220197
Open Access | Times Cited: 7
Phase II Study of Bemnifosbuvir in High-Risk Participants in a Hospital Setting with Moderate COVID-19
Arantxa Horga, Daniel R. Kuritzkes, John J. Kowalczyk, et al.
Future Virology (2023) Vol. 18, Iss. 8, pp. 489-500
Open Access | Times Cited: 7
Cheminformatics Bioprospection of Broad Spectrum Plant Secondary Metabolites Targeting the Spike Proteins of Omicron Variant and Wild-Type SARS-CoV-2
‪Jamiu Olaseni Aribisala, Christiana Eleojo Aruwa, Taofik Olatunde Uthman, et al.
Metabolites (2022) Vol. 12, Iss. 10, pp. 982-982
Open Access | Times Cited: 11
Nirmatrelvir plus ritonavir in COVID-19: a profile of its use
Hannah A. Blair
Drugs & Therapy Perspectives (2022) Vol. 39, Iss. 2, pp. 41-47
Open Access | Times Cited: 11
Metabolites profiling and cheminformatics bioprospection of selected medicinal plants against the main protease and RNA-dependent RNA polymerase of SARS-CoV-2
Adedayo Ayodeji Lanrewaju, Abimbola M. Enitan, Martin M. Nyaga, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 13, pp. 6740-6760
Open Access | Times Cited: 5
Current Insights and Molecular Docking Studies of the Drugs under Clinical Trial as RdRp Inhibitors in COVID-19 Treatment
Amita Verma, Pradeep Kumar, Irine Pauly, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 46, pp. 3677-3705
Closed Access | Times Cited: 9
Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment
Varalakshmi Velagacherla, Akhil Suresh, Chetan Hasmukh Mehta, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 213-213
Open Access | Times Cited: 4
Comparative Performance Evaluation of Personal Protective Measures and Antiviral Agents Against SARS-CoV-2 Variants: A Narrative Review
Md. Anamul Haque, Md. Tanbir, Bulbul Ahamed, et al.
Clinical Pathology (2023) Vol. 16
Open Access | Times Cited: 4
An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines
Dona Susan Mathew, T. Pandya, HC Pandya, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1565-1565
Open Access | Times Cited: 4
Anti-SARS-CoV-2 Biotherapeutics and Chemotherapeutics: An Insight into Product Specifications and Marketing Dynamics
Vijay Kotra, Dinakar Mallem, Anil Kumar Kanuri, et al.
Progress In Microbes & Molecular Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 7
Knowledge, acceptance and perception about COVID-19 vaccines in Bangladesh: Findings from a web-based cross-sectional study
Md. Sakhawat Hossain, Md. Rabiul Islam, Mohammad Touhidul Islam, et al.
Open Health (2022) Vol. 3, Iss. 1, pp. 73-86
Open Access | Times Cited: 6
Combinatorial Regimens Augment Drug Monotherapy for SARS-CoV-2 Clearance in Mice
Irfan Ullah, Fanny Escudié, Ivan Scandale, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top